Clinical Trial Update: Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oral Azelaprag in combination with tirzepatide versus tirzepatide alone in adults with obesity; the study was terminated and reports on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Azelaprag (azelaprag)
• Tirzepatide (tirzepatide)

Snippet

Sponsor: BioAge Labs, Inc. | Conditions: Obesity | Phase 2 | Status: TERMINATED